Source: financeyahoo
Bayer AG Innovation Procurement and Scientist.com have signed a multi-year extension that elevates Scientist.com to Bayer’s preferred global channel for sourcing external R&D services.
The alliance began in 2015, when Bayer adopted Scientist.com’s digital marketplace to streamline and control long-tail spend in preclinical research. Over the years, this relationship has deepened and expanded, reflecting Bayer’s broader shift toward externalizing more of its R&D activities as part of its innovation strategies. What started as a tactical procurement tool has now become Bayer’s preferred global channel for sourcing a wide spectrum of external R&D services.
With the expansion, Scientist.com’s platform will support Bayer across the entire R&D value chain, including:
- Strategic preclinical supplier management, with guided buying, rate-card compliance, and performance tracking.
- Clinical development services, offering unified workflows for study execution, biomarker analysis, and central laboratory capabilities.
- Real-world evidence, data analytics, health economics, and market access solutions, providing rapid access to top-tier data partners.
- Crop science research, including specialized agriscience testing and regulatory studies.
“Scientist.com has proven its value right from the beginning, and this extension makes it the one place our scientists go for most of their external work,” said Dr. Kirstin Meyer, SVP and Head of Pre-clinical Development Research, Bayer AG. “With a single entry point we can reach strategic and niche providers alike, ensure governance, drive our sustainability goals and – critically – generate insights from the aggregated data to guide future decisions.”
“Bayer is showing how a digital procurement orchestration platform can serve as an enterprise solution that streamlines an entire research organization’s sourcing processes,” said Dr. Dan Kagan, President & COO, Scientist.com. “Together we’re adding new AI tools, deeper data integrations and end-to-end compliance so Bayer teams across Pharma and Crop Science can innovate faster and smarter.”